Pfizer (PFE -0.2%) will host its virtual Investor Day on Monday, September 14, from 1:00 pm – 4:00 pm ET and Tuesday, September 15, from 10:00 am – 1:00 pm ET.
Management will present updates on the R&D pipeline with particular emphasis on potential blockbusters expected to launch by 2025.
Speaking at a conference earlier today, CEO Albert Bourla said results from a 30K-subject, late-stage trial of its COVID-19 vaccine candidate BNT162b2 will be available in October. If results are positive, the company plans to immediately file for emergency use authorization with the FDA.
https://seekingalpha.com/news/3611504-pfizer-announces-investor-event-september-14-and-15
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.